PARTNER WITH US
Establish Yourself as the Leading Provider for Europe’s Expanding
Precision Medicine Market
As biopharma race to approve and commercialise ground-breaking drug-diagnostics for oncology, neurological, autoimmune, and rare disease indications, precision medicine priorities have never been higher as they navigate translational, regulatory and launch planning bottlenecks across Europe.
Serving as Europe’s central hub for the precision medicine community, the 15th World Clinical Biomarkers & Companion Diagnostics Summit Europe will unite 170+ Pharma, Biotech, Notified Bodies, Research Institutes and Diagnostic Providers for three days of unrivalled industry networking, knowledge sharing, and learning opportunities.
As our audience gear up to improve patient selection and monitoring, they need support with diagnostic testing, CDx manufacturing, regulatory filing and specialised CROs.
If you offer relevant services and would like to leverage your company within this rapidly evolving space, contact us to discuss a bespoke commercial package to promote your company at this industry-defining forum in April.
3 Reasons to Prioritise Partnering
Gain actionable market insights with over 22 case study-led sessions and high-value Q&A discussions
Connect and build relationships with both existing and future clients trailblazing precision therapies for oncology, neurological, autoimmune, cardiovascular, metabolic, and rare diseases
Demonstrate your solutions to boost your visibility in the growing European CDx market, and position yourself as a trusted thought leader
Accelerate Co-Development Strategies with Strategic Biopharma Leaders from Across Europe, Including:
Countries Represented on the Speaker Faculty Include:
Interested in Partnering?
I’m here to help and happy to set up a call so we can discuss your commercial
objectives within the precision medicine space and establish whether
partnering with this meeting aligns with your strategy.
Who You Will Meet:
